Enhanced Pharmaceutical Compositions for Gynecological Diseases Using Sarcodon Aspratus Extracts
Legal Citation
Summary of the Inventive Concept
The present invention discloses novel pharmaceutical compositions and systems that improve the efficacy, safety, and convenience of Sarcodon aspratus extracts in preventing and treating gynecological diseases, thereby providing better treatment outcomes and improved quality of life for patients.
Background and Problem Solved
The original patent disclosed a pharmaceutical composition containing Sarcodon aspratus extracts for preventing and treating gynecological diseases. However, the existing composition had limitations in terms of absorption rate, efficacy, and potential toxicity. The present invention addresses these limitations by introducing novel formulations, synergistic agents, and diagnostic tools to enhance the therapeutic effects and safety of the extracts.
Detailed Description of the Inventive Concept
The inventive concept comprises four main aspects: (1) a system for preventing or treating gynecological diseases with a faster absorption rate, (2) a method for enhancing the efficacy of Sarcodon aspratus extracts using synergistic agents, (3) a pharmaceutical composition with time-release formulation for sustained release of active ingredients, and (4) a system for personalized treatment using diagnostic tools and adjustable dosage formulations. These aspects are designed to provide quicker relief, improved treatment outcomes, and reduced risk of adverse reactions.
Novelty and Inventive Step
The present invention introduces novel and non-obvious improvements to the original patent, including faster absorption rates, synergistic agents, time-release formulations, and personalized treatment systems. These advancements overcome the limitations of the existing composition and provide a significant enhancement in the treatment of gynecological diseases.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include different synergistic agents, varying time-release formulations, and adaptable diagnostic tools. Additionally, the system could be modified to accommodate different routes of administration, such as topical or injectable formulations.
Potential Commercial Applications and Market
The enhanced pharmaceutical compositions and systems of the present invention have significant commercial potential in the gynecological disease treatment market. The improved efficacy, safety, and convenience of the compositions are expected to appeal to healthcare providers and patients, leading to increased adoption and market share.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/07 |
| A | A61 | A61K9/0056 |
| A | A61 | A61P15/08 |
| A | A61 | A61K2236/333 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions for gynecological disease treatment, specifically focusing on herbal extract-based therapeutic interventions with expertise in pharmacological formulation, drug delivery systems, and botanical medicine
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, pharmacology, or herbal medicine, possessing knowledge of drug formulation techniques, extraction methodologies, and therapeutic agent optimization strategies
Obviousness Rationale
A PHOSITA would recognize that the published technical disclosure represents predictable variations on the source patent's core concept of Sarcodon aspratus extracts for gynecological treatments. The proposed modifications such as time-release formulations, synergistic agents, and personalized diagnostic approaches represent standard pharmaceutical engineering techniques routinely applied to enhance therapeutic efficacy and patient outcomes. These variations demonstrate incremental improvements using well-established pharmaceutical design principles that would be obvious to a skilled practitioner seeking to optimize the original therapeutic composition.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,586 |
|---|---|
| Title | Pharmaceutical composition for preventing or treating gynecological diseases containing Sarcodon aspratus extracts as active ingredient |